Structure Therapeutics Inc. (ADR)
General ticker "GPCR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
Structure Therapeutics Inc. (ADR) follows the US Stock Market performance with the rate: 25.2%.
Estimated limits based on current volatility of 14.9%: low 59.34$, high 80.16$
Factors to consider:
- Total employees count: 68 as of 2022
- Current price 82.5% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [13.94$, 36.95$]
- 2025-12-31 to 2026-12-31 estimated range: [10.85$, 28.90$]
Short-term GPCR quotes
Long-term GPCR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $102.78MM | $158.23MM |
| Operating Income | $-102.78MM | $-158.23MM |
| Non-Operating Income | $13.39MM | $36.01MM |
| R&D Expense | $70.10MM | $108.81MM |
| Income(Loss) | $-89.38MM | $-122.22MM |
| Taxes | $0.24MM | $0.31MM |
| Profit(Loss)* | $-89.62MM | $-122.53MM |
| Stockholders Equity | $452.97MM | $864.84MM |
| Assets | $482.02MM | $903.33MM |
| Operating Cash Flow | $-79.49MM | $-116.64MM |
| Capital expenditure | $2.17MM | $1.29MM |
| Investing Cash Flow | $-268.34MM | $-358.91MM |
| Financing Cash Flow | $451.53MM | $515.26MM |
| Earnings Per Share** | $-2.44 | $-2.33 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.